- Home
- PBH vs CLVT Comparison
PBH vs CLVT Comparison
Compare PBH & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBH
- CLVT
- Stock Information
- Founded
- PBH 1996
- CLVT 2016
- Country
- PBH United States
- CLVT United Kingdom
- Employees
- PBH N/A
- CLVT N/A
- Industry
- PBH Biotechnology: Pharmaceutical Preparations
- CLVT EDP Services
- Sector
- PBH Health Care
- CLVT Technology
- Exchange
- PBH Nasdaq
- CLVT Nasdaq
- Market Cap
- PBH 4.0B
- CLVT 3.3B
- IPO Year
- PBH 2005
- CLVT N/A
- Fundamental
- Price
- PBH $84.17
- CLVT $5.14
- Analyst Decision
- PBH Strong Buy
- CLVT Hold
- Analyst Count
- PBH 3
- CLVT 7
- Target Price
- PBH $83.67
- CLVT $7.25
- AVG Volume (30 Days)
- PBH 306.9K
- CLVT 7.8M
- Earning Date
- PBH 11-07-2024
- CLVT 11-06-2024
- Dividend Yield
- PBH N/A
- CLVT N/A
- EPS Growth
- PBH N/A
- CLVT N/A
- EPS
- PBH 4.10
- CLVT N/A
- Revenue
- PBH $1,110,659,000.00
- CLVT $2,577,400,000.00
- Revenue This Year
- PBH $1.57
- CLVT N/A
- Revenue Next Year
- PBH $2.54
- CLVT $0.46
- P/E Ratio
- PBH $20.41
- CLVT N/A
- Revenue Growth
- PBH N/A
- CLVT N/A
- 52 Week Low
- PBH $56.61
- CLVT $4.25
- 52 Week High
- PBH $84.21
- CLVT $9.61
- Technical
- Relative Strength Index (RSI)
- PBH 80.59
- CLVT 42.00
- Support Level
- PBH $80.35
- CLVT $4.25
- Resistance Level
- PBH $83.83
- CLVT $4.88
- Average True Range (ATR)
- PBH 2.00
- CLVT 0.30
- MACD
- PBH 0.34
- CLVT 0.02
- Stochastic Oscillator
- PBH 99.13
- CLVT 36.33
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.